| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | HAEMONETICS CORP | 5,406,309 | 10.6% | EDGAR |
| SC 13G/A | 2024-02-13 | Neuberger Berman Group LLC | HAEMONETICS CORP | 3,531,181 | 7.0% | EDGAR |
| SC 13G/A | 2024-02-09 | Capital Research Global Investors | HAEMONETICS CORP | 6,523,568 | 12.9% | EDGAR |
| SC 13G/A | 2024-02-08 | WELLINGTON MANAGEMENT GROUP LLP | HAEMONETICS CORP | 3,268,083 | 6.4% | EDGAR |
| SC 13G/A | 2024-01-23 | BlackRock Inc. | HAEMONETICS CORP | 6,056,881 | 11.9% | EDGAR |
| SC 13G/A | 2023-02-13 | Capital Research Global Investors | HAEMONETICS CORP | 5,956,064 | 11.8% | EDGAR |
| SC 13G/A | 2023-02-10 | Neuberger Berman Group LLC | HAEMONETICS CORP | 3,873,436 | 7.6% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | HAEMONETICS CORP | 5,242,836 | 10.4% | EDGAR |
| SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | HAEMONETICS CORP | 4,034,753 | 8.0% | EDGAR |
| SC 13G/A | 2023-01-26 | BlackRock Inc. | HAEMONETICS CORP | 5,898,620 | 11.7% | EDGAR |
| SC 13G/A | 2023-01-20 | BlackRock Inc. | HAEMONETICS CORP | 5,898,620 | 11.7% | EDGAR |
| SC 13G/A | 2022-10-11 | VANGUARD GROUP INC | HAEMONETICS CORP | 5,195,195 | 10.1% | EDGAR |
| SC 13G | 2022-04-08 | Capital Research Global Investors | HAEMONETICS CORP | 5,452,006 | 10.7% | EDGAR |
| SC 13G/A | 2022-02-14 | Neuberger Berman Group LLC | HAEMONETICS CORP | 3,876,521 | 7.6% | EDGAR |
| SC 13G/A | 2022-02-11 | Capital Research Global Investors | HAEMONETICS CORP | 2,049,133 | 4.0% | EDGAR |
| SC 13G/A | 2022-02-10 | WELLINGTON MANAGEMENT GROUP LLP | HAEMONETICS CORP | 5,537,538 | 10.8% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | HAEMONETICS CORP | 4,880,936 | 9.6% | EDGAR |
| SC 13G | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | HAEMONETICS CORP | 5,090,301 | 10.0% | EDGAR |
| SC 13G/A | 2022-01-27 | BlackRock Inc. | HAEMONETICS CORP | 6,692,346 | 13.1% | EDGAR |
| SC 13G/A | 2022-01-25 | BlackRock Inc. | HAEMONETICS CORP | 6,692,346 | 13.1% | EDGAR |